WHO ICTRP trial
Clinical use of 18F-Choline in glial brain tumors - ND
EUCTR2009-011380-37-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2009-011380-37-IT |
|---|---|
| Public title | Clinical use of 18F-Choline in glial brain tumors - ND |
| Scientific title | Clinical use of 18F-Choline in glial brain tumors - ND |
| Primary sponsor | AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Patients with primary tumor likely diagnosis with 18F-FCH PET / CT or patients with local recurrence or distant shapes of the same histological MedDRA version: 9.1 Level: HLT Classification code 10029105 Term: Neoplasms malignant site… |
| Interventions | Product Name: 18F-Choline Pharmaceutical Form: Kit for radiopharmaceutical preparation Concentration unit: mCi millicurie(s) Concentration type: equal Concentration number: 10- |
| Registration date | Mar 16, 2009 |
| Secondary IDs | MN6 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: